This document presents an investment opportunity in a new healthcare insurance product called The New Face of Healthcare. It summarizes the business model, which involves licensing the product to major insurance companies to provide additional benefits to policyholders. The management team has extensive experience in healthcare and insurance. The presentation seeks $3.75 million to fund product launch and operations, with the goal of capturing 1.23% of the $900 billion health insurance marketplace within 5 years. It notes the high-risk nature of the investment but also the large market opportunity and proprietary product.

1. 1/16/2015
1
Created by Glen J. Reaux
Copyright © 2013, revised 2014 - Glen J. Reaux all rights reserved
NOTICE
Names and logos of certain companies are used in this presentation. They are used as
examples in explaining products and serves. They in no way imply nor do they mean to
imply any form of partnership or agreement between these companies and LiveWell
Insurance Products Incorporated. No such agreements exist.
TM
The New Face of Healthcare!
SM
THE OPPORTUNITY
We make the insurance companies products
better by:
Paying out of pocket and deductibles not paid
by insurance companies
Making unaffordable healthcare cost affordable
Increasing profits, retention rates, market share

2. 1/16/2015
2
MANAGEMENT TEAM
Glen Reaux, CEO – 33 years management, marketing,
advertising, media relations & TV productions
Owen Ellington, COO – M.D., J.D, Amerigroup,
Medical Director
Herman Wright, CMO – J.D., Amerigroup, National
Marketing VP
Kevin Moten, VP – Corporate Communications
Gordon Reaux, AVP – Operations, UTA, Graduated
Magna Cum Laude
ADVISORY BOARD
Lorenzo Childress, Advisory Board Member–M.D., J.D., Former
Executive Vice President Amerigroup (Founding Medical Director)
Robert Currie, Advisory Board Member
President Community Care Alliance Chicago, Il.
Former COO Aetna Better Health State of Illinois
Milton Thibodeaux, Advisory Board Member, Financial Consultant
President Greater Houston Business Procurement Forum
Former Project Director Houston Minority Business Development
(Enterprise) Center
Former Manager Grant Thornton Accounting Firm

3. 1/16/2015
3
TheNewFaceofHealthcare
Reduces and eliminates co-pays & deductibles
Provides additional money for hospital and
medical bills
Can be added to existing health plans
Does not increase monthly premiums
Patent Pending
TM
HEALTH INSURANCE
MARKETPLACE $900BnBlue Cross & Blue Shield Group 99,000,000
Wellpoint Inc. 36,100,000
United Healthcare Group 18,000,000
Aetna Group 15,800,000
Cigna 12,000,000
Health Net Group 10,000,000
Kaiser Permanente 8,700,000
Humana Group 6,400,000
Coventry Corp. Group 4,700,000
Assurant 1,000,0000
Affordable Care Act 32,000,000
Total 243,700,000

4. 1/16/2015
4
BUSINESS MODEL
Licensing Fees – Insurance Companies
Marketing Fees – Marketing Partners
Insurance Companies are the end-user, they
provide our cobranded or private label products
to their existing and future customer base.
Target Market 3,000,000 users or 1.23% of market-
place share of top 10 companies.
COMPETITION
First in marketplace.
Patent Pending

5. 1/16/2015
5
MARKET STRATEGY
License product to Insurance Companies
Establish Marketing Partners
Target Market 1.23% or 3million members of
the 243.7 million in the marketplace.
VALUE ADDED BENEFITS
Increase retention rate
Increase market share
Enhanced brand recognition and loyalty
Turn Key Operation
Patent Pending – exclusive proprietary

6. 1/16/2015
6
CAPITALIZATION
Startup Capital - $350K
Marketing, strategic partnerships, distribution,
infrastructure, personnel, travel
Product Launch / Operations - $3.75mil
REASONS TO INVESTMENT
Favorable Risk vs Reward - Exceptionally High Return
Huge $900 Billion National Market (Health Insurance)
Great Product, Market Disruptor, New, Proprietary,
Patent Pending, Timely
Annual EBITDA $350 Milllion after 5 years,
Exceptionally Strong Management Team

7. 1/16/2015
7
INVESTMENT DISCLAIMER
Warnings
THIS IS A SPECULATIVE INVESTMENT AND INVOLVES A HIGH DEGREE OF
RISK. THERE IS NO PUBLIC MARKET FOR THIS INVESTMENT. ANY
INVESTMENT SHOULD BE DISCUSSED AND REVIEWED BY A FINANCIAL
AND/OR LEGAL ADVISOR.
Exemptions from Registration
THIS INVESTMENT HAS NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933 NOR ANY OTHER APPLICABLE SECURITIES LAW. THIS
INVESTMENT HAS NOT BEEN APPROVED OR DISAPPROVED BY THE U.S.
SECURITIES AND EXCHANGE COMMISSION NOR THE SECURITIES
ADMINISTRATOR OF ANY STATE, AND NEITHER HAS PASSED UPON THE
ACCURACY OR ADEQUACY OF THIS PRESENTATION. ANY REPRESENTATION
TO THE CONTRARY IS A CRIMINAL OFFENSE. THE INTERESTS ARE OFFERED
ONLY TO THOSE INVESTORS WHO UNDERSTAND THE INHERENT RISK IN
INVESTMENTS OF THIS NATURE.